The Motley Fool

Why fat dividends from Standard Life Aberdeen plc leave me cold

News that Standard Life Aberdeen (LSE: SLA) plans to sell the majority of its insurance business to smaller rival Phoenix Group eclipsed SLA’s full-year results today.

The deal involves a cash consideration of £2.28bn and a shareholding of 19.99% in Phoenix Group, which will be part of an expansion and “significant enhancement” of the two firms’ existing long-term strategic partnership. The sale will see Standard Life Aberdeen disposing of its Standard Life Assurance Limited division but retaining its UK retail platforms and financial advice business. The two firms aim to continue to work together with Standard Life Aberdeen being Phoenix Group’s asset management partner for the business acquired by Phoenix.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Pedestrian figures

The pace of change is frenetic. Standard Life only just merged with Aberdeen Asset Management in 2017, but the directors explain that this new proposed transaction “completes the transformation to a fee-based capital-light business and is a major step towards the creation of a world-class investment company.” The question now becomes, do you want to invest in an investment company?

For what it’s worth, today’s full-year figures are a little pedestrian. Assets under management and administration were just 1% higher than the year before, fee-based revenue crept up almost 3%, adjusted diluted earnings per share came in broadly flat and the adjusted figure for cash generation sank by 6%. Undeterred, and in an expression of confidence about the firm’s future, the directors pushed up the full-year dividend by almost 7.5%.

The presence of a fat dividend yield is one of the first things that jumps out at you when you look at the stock. At today’s share price near 394p, the historical dividend yield sits at about 5.4% and the price-to-earnings ratio is about 13. Good value? Maybe, but following these big changes in the business, the firm has got it all to prove, I reckon.

Beware of the inherent cyclicality

I wouldn’t buy the shares just to harvest the dividend. Even after disposing of its insurance operations the company will remain in the wider financial services sector as an investment company, which means there will be a high degree of cyclicality in the enterprise. Cyclical firms have their place in the investment landscape, but I would not try to use them as vehicles for a long-term buy-and-hold investment strategy.

My guess is that the market will keep the firm’s valuation pegged low in the future and its dividend yield high. But there would be a good reason for that. At some point, the general economic sun will stop shining and firms such as Standard Life Aberdeen could see their profits plummet, which would not be good for investor dividends or the share price.

So I’m going to watch developments at the company with interest. But I don’t think the firm will be able to generate the evergreen cash flows that I’m looking for to back my retirement investments. The last thing I want is for the shares and the underlying business to be in a cyclical slump when I’m ready to draw on my retirement funds, which is why the fat dividend from Standard Life Aberdeen leaves me cold.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US $12.3 TRILLION out of thin air…

And if you click here, we’ll show you something that could be key to unlocking 5G’s full potential...

It’s just ONE innovation from a little-known US company that has quietly spent years preparing for this exact moment…

But you need to get in before the crowd catches onto this ‘sleeping giant’.

Click here to learn more.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has recommended Standard Life Aberdeen. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.